Biogen to start shipping new Alzheimer's drug in two weeks

More than 900 clinics and hospitals around the US are ready to administer Biogen's recently-approved drug Aduhelm to Alzheimer's patients.
Photo: BRIAN SNYDER/REUTERS / X90051
Photo: BRIAN SNYDER/REUTERS / X90051
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Significantly more infusion centers than expected are ready to give patients suffering from Alzheimer's disease Biogen's new medication Aduhelm, according to Fiercepharma.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading